Ceritinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso CAS NO:NA chemically represented as N-(5-Chloro-2-((2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(isopropylsulfonyl)phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso.We supply Ceritinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014903 |
| CAS No | NA |
| Mol.F. | C30H23Cl2N7O |
| Mol.Wt. | 568.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014904 |
| CAS No | NA |
| Mol.F. | C30H22Cl2N8O2 |
| Mol.Wt. | 597.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014905 |
| CAS No | NA |
| Mol.F. | C18H20ClN5O2 |
| Mol.Wt. | 373.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014906 |
| CAS No | NA |
| Mol.F. | C18H13F4N3O5S |
| Mol.Wt. | 459.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014907 |
| CAS No | NA |
| Mol.F. | C15H16BrN3O |
| Mol.Wt. | 334.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014908 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014909 |
| CAS No | 55557-00-1 |
| Mol.F. | C5H10N4O2 |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014910 |
| CAS No | 50270-42-3 |
| Mol.F. | C11H14N2O3 |
| Mol.Wt. | 222.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014911 |
| CAS No | 37620-20-5 |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014912 |
| CAS No | 75195-76-5 |
| Mol.F. | C9H11N3O2 |
| Mol.Wt. | 193.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014913 |
| CAS No | NA |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014914 |
| CAS No | NA |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014915 |
| CAS No | NA |
| Mol.F. | C9H12N2O6S |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014916 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014917 |
| CAS No | NA |
| Mol.F. | C9H10N2O4 |
| Mol.Wt. | 210.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014918 |
| CAS No | NA |
| Mol.F. | C29H30N8O2 |
| Mol.Wt. | 522.6 |
| INV STATUS | CUSTOM SYNTHESIS |